Bayramoglu A, Urhan Kucuk M, Guler HI, Abaci O, Kucukkaya Y, Colak E (2015) Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension? Cytotechnology 67(1):115–122
Article
CAS
Google Scholar
McAuley E, McNulty H, Hughes C, Strain JJ, Ward M (2016) Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition. Proc Nutr Soc 75(3):405–414
Article
CAS
Google Scholar
Yang B, Fan S, Zhi X, Li Y, Liu Y, Wang D et al (2014) Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls. PLoS ONE 9(2):e87497
Article
Google Scholar
Nassereddine S, Kassogue Y, Korchi F, Habbal R, Nadifi S (2015) Association of methylenetetrahydrofolate reductase gene (C677T) with the risk of hypertension in Morocco. BMC Res Notes 8:775
Article
Google Scholar
Heux S, Morin F, Lea RA, Ovcaric M, Tajouri L, Griffiths LR (2004) The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res 27(9):663–667
Article
CAS
Google Scholar
Ergul E, Sazci A, Kara I (2012) Methylenetetrahydrofolate reductase gene polymorphisms in Turkish children with attention-deficit/hyperactivity disorder. Genet Test Mol Biomark 16(1):67–69
Article
CAS
Google Scholar
Fridman O, Porcile R, Morales AV, Gariglio LO, Potenzoni MA, Turk Noceto PC (2013) Association of methylenetetrahydrofolate reductase gene 677C>T polymorphism with hypertension in older women in a population of Buenos Aires City. Clin Exp Hypertens 35(3):159–166
Article
CAS
Google Scholar
McNulty H, Strain JJ, Hughes CF, Ward M (2017) Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension. Mol Aspects Med 53:2–9
Article
CAS
Google Scholar
Klarin D, Emdin CA, Natarajan P, Conrad MF, INVENT Consortium, Kathiresan S (2017) Genetic analysis of venous thromboembolism in UK biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet 10(2):e001643
Article
CAS
Google Scholar
Zoller B, Svensson PJ, Dahlback B, Lind-Hallden C, Hallden C, Elf J (2020) Genetic risk factors for venous thromboembolism. Expert Rev Hematol 13(9):971–981
Article
Google Scholar
Staines-Urias E, Paez MC, Doyle P, Dudbridge F, Serrano NC, Ioannidis JP et al (2012) Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. Int J Epidemiol 41(6):1764–1775
Article
Google Scholar
Li Y, Ruan Y (2019) Association of hypertensive disorders of pregnancy risk and factor V Leiden mutation: a meta-analysis. J Obstet Gynaecol Res 45(7):1303–1310
Article
CAS
Google Scholar
Demirel Y, Dogan S, Uludag A, Silan C, Atik S, Silan F et al (2011) Combined effect of Factor V Leiden, MTHFR, and angiotensin-converting enzyme (insertion/deletion) gene mutations in hypertensive adult individuals: a population-based study from Sivas and Canakkale, Turkey. Genet Test Mol Biomark 15(11):785–791
Article
CAS
Google Scholar
Makris TK, Krespi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, Triposkiadis FK et al (2000) Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. Am J Hypertens 13(1 Pt 1):61–65
Article
CAS
Google Scholar
Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J et al (2013) Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 28(8):621–647
Article
CAS
Google Scholar
Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM (2000) The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol 111(4):1223–1229
CAS
PubMed
Google Scholar
Lynch AI, Eckfeldt JH, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C et al (2012) Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Pharmacogenet Genom 22(5):355–366
Article
CAS
Google Scholar
Khidri FF, Waryah YM, Ali FK, Shaikh H, Ujjan ID, Waryah AM (2019) MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study. BMC Med Genet 20(1):163
Article
Google Scholar
Kruse L, Mitchell AM, Camargo CA Jr, Hernandez J, Kline JA (2006) Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department. Clin Chem 52(6):1026–1032
Article
CAS
Google Scholar
Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11(2):116–128
Article
CAS
Google Scholar
Ghogomu SM, Ngolle NE, Mouliom RN, Asa BF (2016) Association between the MTHFR C677T gene polymorphism and essential hypertension in South West Cameroon. Genet Mol Res 15(1):28
Article
Google Scholar
Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M et al (2003) Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40(8):619–625
Article
CAS
Google Scholar
Ravera M, Viazzi F, Berruti V, Leoncini G, Zagami P, Bezante GP et al (2001) 5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. Am J Hypertens 14(4 Pt 1):371–376
Article
CAS
Google Scholar
Ilhan N, Kucuksu M, Kaman D, Ilhan N, Ozbay Y (2008) The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 39(1):125–130
Article
CAS
Google Scholar
Yang KM, Jia J, Mao LN, Men C, Tang KT, Li YY et al (2014) Methylenetetrahydrofolate reductase C677T gene polymorphism and essential hypertension: a meta-analysis of 10,415 subjects. Biomed Rep 2(5):699–708
Article
CAS
Google Scholar
Amrani-Midoun A, Kiando SR, Treard C, Jeunemaitre X, Bouatia-Naji N (2016) The relationship between MTHFR C677T gene polymorphism and essential hypertension in a sample of an Algerian population of Oran city. Int J Cardiol 225:408–411
Article
Google Scholar
Wu X, Yang K, Tang X, Sa Y, Zhou R, Liu J et al (2015) Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for preeclampsia: a meta-analysis. J Assist Reprod Genet 32(5):797–805
Article
Google Scholar
Horigan G, McNulty H, Ward M, Strain JJ, Purvis J, Scott JM (2010) Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C–>T polymorphism in MTHFR. J Hypertens 28(3):478–486
Article
CAS
Google Scholar
Wilson CP, McNulty H, Ward M, Strain JJ, Trouton TG, Hoeft BA et al (2013) Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension 61(6):1302–1308
Article
CAS
Google Scholar
Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H et al (1999) Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 86(4):380–384
Article
CAS
Google Scholar
Wu YL, Hu CY, Lu SS, Gong FF, Feng F, Qian ZZ et al (2014) Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis. Metabolism 63(12):1503–1511
Article
CAS
Google Scholar
Witcher PM, Chez BF, Baird SM (2015) Multisystem effects of hypertensive disorders of pregnancy: a comprehensive review. J Perinat Neonatal Nurs 29(3):229–239
Article
Google Scholar
Ali SM, Khalil RA (2015) Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets 19(11):1495–1515
Article
CAS
Google Scholar
Higgins JR, Kaiser T, Moses EK, North R, Brennecke SP (2000) Prothrombin G20210A mutation: is it associated with pre-eclampsia? Gynecol Obstet Investig 50(4):254–257
Article
CAS
Google Scholar
Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J et al (2020) Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism—a meta-analysis and systematic review. Vasa 49(2):141–146
Article
Google Scholar
Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ (2012) Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women. Chin Med J (Engl) 125(7):1249–1253
CAS
Google Scholar
UniProt. UniProtKB - P05121 (PAI1_HUMAN). 10 April 2018 ed2018